Cemented TrendHip® - Multicenter PMCF Study on Total Indications (TRESTI)
Post Market Clinical Follow-Up (PMCF) Study to Evaluate the Performance and Safety of the Cemented TrendHip® Stem in a Prospective Follow-up Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Maria D Fernandez, Dr.
- Phone Number: +49-7461-95-0
- Email: maria_dolores.fernandez@aesculap.de
Study Contact Backup
- Name: Stefan Maenz, Dr.
Study Locations
-
-
-
Brakel, Germany, 33034
- St. Vincenz Hospital Brakel
-
Mülheim, Germany, 45468
- St. Marien-Hospital
-
Plettenberg, Germany, 58840
- radprax Krankenhaus Plettenberg GmbH
-
-
North Rhine-Westphalia
-
Ahlen, North Rhine-Westphalia, Germany, 59227
- St. Franziskus-Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion: Inclusion criteria
- Patient older than 18 years.
- Patient who undergo / underwent a hip arthroplasty with cemented TrendHip® femoral stem according to the indications for implantation specified in the Instructions for Use.
- Patient not opposing participation in the study.
Exclusion: Exclusion criteria
- Patient with shortened life expectancy.
- The patient is unable to commit to the planned follow-up period.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: TrendHip®
|
cemented hip arthroplasty
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of functional outcome over five year follow-up period (modified Harris Hip Score)
Time Frame: preoperative (as available) and at two examinations during Follow-Up (1 year postop, 5 years postop)
|
The modified Harris Hip Score (mHHS) as patient-reported outcome measure and evaluated one-year and five-years postoperatively.
The mHHS is a validated and disease-specific instrument commonly used to assess outcomes in total hip arthroplasty.
The domains covered are pain, function (gait), and functional activities.
|
preoperative (as available) and at two examinations during Follow-Up (1 year postop, 5 years postop)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Assessment
Time Frame: at two examinations during Follow-Up (1 year postop, 5 years postop)
|
Pain will be measured with a Visual Analogue Scale (VAS), at rest and when walking on flat ground.
The Visual Analog Scale (VAS) is a 10 cm line with anchor statements on the left (no pain) and on the right (extreme pain).
The patients are asked to mark their current pain level on the line.
|
at two examinations during Follow-Up (1 year postop, 5 years postop)
|
|
Patient satisfaction with surgery result
Time Frame: at two examinations during Follow-Up (1 year postop, 5 years postop)
|
Patient is asked for satisfaction with surgery result with a 4-point scale: very satisfied, satisfied, unsatisfied, very unsatisfied
|
at two examinations during Follow-Up (1 year postop, 5 years postop)
|
|
Survival rate (Kaplan-Meier)
Time Frame: at two examinations during Follow-Up (1 year postop, 5 years postop)
|
The survival of the TrendHip® Total Hip Prothesis will be analyzed using the "Kaplan-Meier".
|
at two examinations during Follow-Up (1 year postop, 5 years postop)
|
|
Radiological Outcome: Migration of the stem in mm
Time Frame: at two examinations during Follow-Up (1 year postop, 5 years postop)
|
Migration of the stem is assessed in [mm] relative to postoperative x-rays
|
at two examinations during Follow-Up (1 year postop, 5 years postop)
|
|
Radiological Outcome: Evaluation of bony osseointegration or conspicuous features of the stem
Time Frame: at two examinations during Follow-Up (1 year postop, 5 years postop)
|
Bony Osseointegration or conspicuous features of the stem are assessed on anterior-posterior and lateral x-rays of the stem and will be analysed according to the zones defined by Gruen.
"Charnley" and "Gruen" zones of the hip are distinct zones used in assessment of aseptic loosening in total hip joint replacements
|
at two examinations during Follow-Up (1 year postop, 5 years postop)
|
|
Radiological Outcome: Heterotopic Ossification
Time Frame: at two examinations during Follow-Up (1 year postop, 5 years postop)
|
Brooker classification divides heterotopic ossifications that form following total hip replacement to four classes.
Class I: islands of bone within soft tissues around hip; Class II: bone spurs in pelvis or proximal end of femur leaving ≥1 cm between the opposing bone surfaces; Class III: bone spurs that extend from pelvis or the proximal end of femur, which reduce the space between the opposing bone surfaces to <1cm; Class IV: ankylosis of the hip on x-ray
|
at two examinations during Follow-Up (1 year postop, 5 years postop)
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Adverse and Serious Adverse Events
Time Frame: at two examinations during Follow-Up (1 year postop, 5 years postop)
|
All Adverse Events (AE) / Serious Adverse Events (SAE) observed during the follow-up examination or reported by the patient will be documented.
Only those AE and SAE that could be related to the investigational product or the TrendHip® Total Hip Arthroplasty procedure are of interest.
|
at two examinations during Follow-Up (1 year postop, 5 years postop)
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Bone Diseases
- Musculoskeletal Diseases
- Wounds and Injuries
- Pathologic Processes
- Arthritis
- Joint Diseases
- Rheumatic Diseases
- Connective Tissue Diseases
- Autoimmune Diseases
- Immune System Diseases
- Leg Injuries
- Necrosis
- Fractures, Bone
- Osteoarthritis
- Femoral Fractures
- Hip Injuries
- Joint Dislocations
- Osteonecrosis
- Pathological Conditions, Signs and Symptoms
- Skin and Connective Tissue Diseases
- Arthritis, Rheumatoid
- Hip Fractures
- Osteoarthritis, Hip
- Hip Dislocation
- Femur Head Necrosis
- Surgical Procedures, Operative
- Arthroplasty, Replacement
- Arthroplasty
- Orthopedic Procedures
- Plastic Surgery Procedures
- Prosthesis Implantation
- Arthroplasty, Replacement, Hip
Other Study ID Numbers
Other Study ID Numbers
- AAG-O-H-2105
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.